Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Edwards v. CoreValve in U.K.

This article was originally published in The Gray Sheet

Executive Summary

CoreValve and Edwards Lifesciences each claimed victories Jan. 9 in patent infringement cases involving competing transcatheter valve technology. A U.K. court found the product design for CoreValve's ReValving system for transcatheter aortic valve replacement does not infringe on a patent held by Edwards. But the court also upheld the validity of Edwards' U.K. Andersen patent for transcatheter valve technology, dismissing a CoreValve suit. An Edwards lawsuit against CoreValve in the U.S., citing infringement against the U.S. patent for the same technology, is still pending (1"The Gray Sheet" Feb. 18, 2008, In Brief). The ReValving system is not available in the U.S
Advertisement

Related Content

Topics

Advertisement
UsernamePublicRestriction

Register

MT027028

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel